The genetic basis of spondyloarthritis

Annals of the Rheumatic Diseases

Volumn 70, Issue SUPPL. 1, 2011, Pages

  Reveille, John D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; HLA B60 ANTIGEN; HLA C ANTIGEN; INTERLEUKIN 12P40; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 23P19; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; AMINOPEPTIDASE; ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 1A; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3 INTERACTING PROTEIN 1; UNCLASSIFIED DRUG;

ACUTE ANTERIOR UVEITIS; ANKYLOSING SPONDYLITIS; AUTOPHAGY; CHROMOSOME 9P; CONFERENCE PAPER; CYTOKINE PRODUCTION; ENTERITIS; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; IRIDOCYCLITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; TH17 CELL; COLONOSCOPY; DISEASE PREDISPOSITION; ERAP1 GENE; GENE; GENE IDENTIFICATION; GENETIC ANALYSIS; IL 23R GENE; PROTEIN FUNCTION; TNFAIP3 GENE; TNIP1 GENE; GENETICS; REVIEW; SPONDYLARTHRITIS;

GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HUMANS; INFLAMMATORY BOWEL DISEASES; MAJOR HISTOCOMPATIBILITY COMPLEX; PSORIASIS; SPONDYLARTHRITIS; SPONDYLITIS, ANKYLOSING;

EID: 79953004299     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.140574     Document Type: Conference Paper

References (60)

1. Brown MA, Laval SH, Brophy S, et al. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis 2000;59:883-6.
2. Brown MA, Kennedy LG, MacGregor AJ, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997;40:1823-8. (Pubitemid 27452533)
3. Reveille JD. Recent studies on the genetic basis of ankylosing spondylitis. Curr Rheumatol Rep 2009;11:340-8.
4. Reveille JD, Maganti RM. Subtypes of HLA-B27: history and implications in the pathogenesis of ankylosing spondylitis. Adv Exp Med Biol 2009;649:159-76.
5. Galocha B, de Castro JA. Folding of HLA-B27 subtypes is determined by the global effect of polymorphic residues and shows incomplete correspondence to ankylosing spondylitis. Arthritis Rheum 2008;58:401-12. (Pubitemid 351294875)
6. Chalmers IM. Ankylosing spondylitis in African Blacks. Arthritis Rheum 1980; 23:1366-70. (Pubitemid 11199876)
7. Hill AV, Allsopp CE, Kwiatkowski D, et al. HLA class I typing by PCR: HLA-B27 and an African B27 subtype. Lancet 1991;337:640-2.
8. Gonzalez-Roces S, Alvarez MV, Gonzalez S, et al. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 1997;49:116-23. (Pubitemid 27084693)
9. Khan MA. Race-related differences in HLA association with ankylosing spondylitis and Reiter's disease in American blacks and whites. J Natl Med Assoc 1978;70:41-2. (Pubitemid 9020480)
10. Díaz-Peña R, Blanco-Gelaz MA, Njobvu P, et al. Influence of HLA-B*5703 and HLA-B* 1403 on susceptibility to spondyloarthropathies in the Zambian population. J Rheumatol 2008;35:2236-40.
11. Gérard HC, Branigan PJ, Schumacher HR, Jr, et al. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol 1998;25:734-42. (Pubitemid 28212384)
12. van der Linden SM, Valkenburg HA, de Jongh BM, et al. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984;27:241-9.
13. Robinson WP, van der Linden SM, Khan MA, et al. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum 1989;32:1135-41. (Pubitemid 19237868)
14. Brown MA, Pile KD, Kennedy LG, et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 1996;55:268-70. (Pubitemid 26120706)
15. Wei JC, Tsai WC, Lin HS, et al. HLA-B60 and B61 are strongly associated with ankylosing spondylitis in HLA-B27-negative Taiwan Chinese patients. Rheumatology (Oxford) 2004;43:839-42. (Pubitemid 38996956)
16. Vargas-Alarcón G, Garcia A, Bahena S, et al. HLA-B alleles and complotypes in Mexican patients with seronegative spondyloarthropathies. Ann Rheum Dis 1994;53:755-8. (Pubitemid 24347504)
17. Sims AM, Timms AE, Bruges-Armas J, et al. International Genetics of Ankylosing Spondylitis. Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis 2008;67:1305-9.
18. WTCCC/TASC. Association scan of 14,500 nsSNPs in four common diseases identifies variants involved in autoimmunity. Nat Genet 2007; 39 :1329-37.
19. Maksymowych WP, Inman RD, Gladman DD, et al. Association of a specific ERAP1/ ARTS1 haplotype with disease susceptibility in ankylosing spondylitis. Arthritis Rheum 2009;60:1317-23.
20. Tsui FW, Haroon N, Reveille JD, et al. Association of an ERAP1 ERAP2 haplotype with familial ankylosing spondylitis. Ann Rheum Dis 2010;69:733-6.
21. Pimentel-Santos FM, Ligeiro D, Matos M, et al. Association of IL23R and ERAP1 genes with ankylosing spondylitis in a Portuguese population. Clin Exp Rheumatol 2009;27:800-6.
22. Pazár B, Sáfrány E, Gergely P, et al. Association of ARTS1 gene polymorphisms with ankylosing spondylitis in the Hungarian population: the rs27044 variant is associated with HLA-B*2705 subtype in Hungarian patients with ankylosing spondylitis. J Rheumatol 2010;37:379-84.
23. Davidson SI, Wu X, Liu Y, et al. Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum 2009;60:3263-8.
24. Yan J, Parekh VV, Mendez-Fernandez Y, et al. In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules. J Exp Med 2006;203:647-59.
25. Cui X, Hawari F, Alsaaty S, et al. Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. J Clin Invest 2002;110:515-26. (Pubitemid 34919706)
26. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314:1461-3. (Pubitemid 44871953)
27. Cargill M, Schrodi SJ, Chang M, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007;80:273-90. (Pubitemid 46175676)
28. Karaderi T, Harvey D, Farrar C, et al. Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series. Rheumatology (Oxford) 2009;48:386-9.
29. Rahman P, Inman RD, Gladman DD, et al. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheum 2008;58:1020-5. (Pubitemid 351564003)
30. Rueda B, Orozco G, Raya E, et al. The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann Rheum Dis 2008;67:1451-4.
31. Sung IH, Kim TH, Bang SY, et al. IL-23R polymorphisms in patients with ankylosing spondylitis in Korea. J Rheumatol 2009;36:1003-5.
32. Reveille JD, Sims AM, Danoy P, et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 2010;42:123-7.
33. Kugathasan S, Baldassano RN, Bradfield JP, et al. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet 2008;40:1211-15.
34. Hanks S, Adams S, Douglas J, et al. Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet 2003;73:791-800. (Pubitemid 37271883)
35. Davidson S, Danoy P, Thomas GP, et al. Association of STAT3 and TNFSF1A with ankylosing spondylitis in Han Chinese. Ann Rheum Dis 2010;( In Press ).
36. Danoy P, Pryce K, Hadler J, et al. Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease. PLoS Genet 2010; 6:e1001195.
37. Martin TM, Zhang G, Luo J, et al. A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis Rheum 2005;52:269-74. (Pubitemid 40129257)
38. Chandran V, Schentag CT, Brockbank JE, et al. Familial aggregation of psoriatic arthritis. Ann Rheum Dis 2009;68:664-7.
39. Johnston A, Gudjonsson JE, Sigmundsdottir H, et al. Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8(+) T cells. Clin Exp Immunol 2004; 138:83-93. (Pubitemid 39279969)
40. Nair RP, Stuart P, Henseler T, et al. Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet 2000;66:1833-44. (Pubitemid 30480090)
41. Elder JT. Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis. Genes Immun 2009;10:201-9.
42. Nair RP, Duffin KC, Helms C, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 2009;41:199-204.
43. Zhang XJ, Huang W, Yang S, et al. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat Genet 2009;41:205-10.
44. Strange A, Capon F, Spencer CC, et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 2010;42:985-90.
45. Ravindran JS, Owen P, Lagan A, et al. Interleukin 1alpha, interleukin 1beta and interleukin 1 receptor gene polymorphisms in psoriatic arthritis. Rheumatology (Oxford) 2004;43:22-6. (Pubitemid 38088363)
46. Peddle L, Butt C, Snelgrove T, et al. Interleukin (IL) 1alpha, IL1beta, IL receptor antagonist, and IL10 polymorphisms in psoriatic arthritis. Ann Rheum Dis 2005;64:1093-4. (Pubitemid 40909534)
47. Chang M, Li Y, Yan C, et al. Variants in the 5q31 cytokine gene cluster are associated with psoriasis. Genes Immun 2008;9:176-81. (Pubitemid 351351659)
48. Duffin KC, Freeny IC, Schrodi SJ, et al. Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking. J Invest Dermatol 2009;129:2777-83.
49. Liu Y, Helms C, Liao W, et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 2008;4:e1000041.
50. Mielants H, Veys EM, Goemaere S, et al. Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study. J Rheumatol 1991;18:1542-51.
51. Leirisalo-Repo M, Turunen U, Stenman S, et al. High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum 1994;37:23-31. (Pubitemid 24027690)
52. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603. (Pubitemid 32531408)
53. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6. (Pubitemid 32531409)
54. Peltekova VD, Wintle RF, Rubin LA, et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 2004;36:471-5. (Pubitemid 38620030)
55. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007;39:596-604. (Pubitemid 46676115)
56. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007;39:207-11. (Pubitemid 46184351)
57. Cooney R, Baker J, Brain O, et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 2010; 16:90-7.
58. Imielinski M, Baldassano RN, Griffiths A, et al. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet 2009;41:1335-40.
59. McGovern DP, Jones MR, Taylor KD, et al. Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease. Hum Mol Genet 2010;19:3468-76.
60. McGovern DP, Gardet A, Törkvist L, et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet 2010;42:332-7.